RecruitingNot ApplicableNCT06570122

Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents

Effectiveness of AI-powered Mobile Phone-based Interventions in Parental Smoking Cessation


Sponsor

Beijing Normal University

Enrollment

300 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called 5A's/5R's advice, a behavioral approach called AI-powered chatbot support, and others for people with smoking cessation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORAL5A's/5R's advice

5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.

OTHERHealth warning leaflet

The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.

BEHAVIORALAI-powered chatbot support

Participants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.


Locations(1)

Beijing Normal University

Zhuhai, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06570122


Related Trials